In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...

Cases of dementia in the U.S. are expected to steadily rise in the coming years, hitting 1 million annual cases by 2060.

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Discover how a groundbreaking cognitive assessment tool is transforming early dementia detection with 99.9% accuracy and what this means for future treatment.

More than six million Americans age 65 and up are living with Alzheimer’s including more than 35,000 Nebraska residents.

Digital mental health platforms were supposed to expand access for the neediest patients. Researchers say that hasn’t ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

In response to increasing needs for dementia care and prevention in the aging population, a new medical practice is opening in Vienna. Sunday Health, a medical practice launched in mid-2024, ...

Zoom out: The hidden harms of wildfire smoke don't stop there. A study released last May from Oregon Health & Science ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

The decision by Trump’s team to tap Heather Flick as HHS chief of staff signals an effort to keep closer watch on the ...

With the school holidays just around the corner, many families will hit the road for long-awaited trips and quality time ...